Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
28th Dec 18 Source: CRO
- €2.9 billion turnover
-
-€3.6 billion
profit - 3,517 employees
-
29th Dec 17 Source: Company
- €3.3 billion turnover
-
-€135 million
profit - 4,089 employees
- 2 more years available »
Ranking
By Turnover
(€2.9 billion)- 38th in Top Companies
By Employees
(3,517)- 66th in Top Companies
- 3,517
- €2.9 billion
Employees
- David Keenan Vice President}
Latest News
- 5:00pm ‘I had a choice: get another job or start a company’
- 4:15pm Tixserve signs deal to provide digital tickets at Twickenham
- 3:00pm ‘I love the excitement of winning deals and building products’
- 2:47pm Eddie O’Connor seeks €10m for new venture
- 1:04pm ‘Best piece of advice was focus on the customer’